17β-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 2, 2014, Pages 326-343

  Zhou, Jing ^a,b,c   Lu, Ping ^a,b   Ren, Hao ^a,b   Zheng, Zefeng ^a,b   Ji, Junfeng ^a,b   Liu, Hua ^a,b   Jiang, Fangzhen ^a   Ling, Shucai ^c   Heng, Boon Chin ^d   Hu, Xueqing ^a   Ouyang, Hongwei ^a,b,e  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Zhejiang Provincial Key Laboratory of Tissue Engineering and Regenerative Medicine   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d ETH ZURICH   (Switzerland)

^e ZHEJIANG UNIVERSITY   (China)

Author keywords

17 estradiol; Cell transplantation; hEASCs; Spinal cord injury

Indexed keywords

RATTUS;

ESTRADIOL; HYDROGEN PEROXIDE; SIGNAL PEPTIDE;

17-Β-ESTRADIOL; ADIPOSE TISSUE; ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL TRANSPLANTATION; CONVALESCENCE; CYTOLOGY; DRUG EFFECT; EYELID; GRAFT SURVIVAL; HEASCS; HUMAN; IMMUNOLOGY; MALE; PATHOLOGY; RAT; SECRETION (PROCESS); SPINAL CORD INJURY; SPRAGUE DAWLEY RAT; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; XENOGRAFT;

17-Β-ESTRADIOL; CELL TRANSPLANTATION; HEASCS; SPINAL CORD INJURY;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; ESTRADIOL; EYELIDS; GRAFT SURVIVAL; HUMANS; HYDROGEN PEROXIDE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 84893671954     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12191     Document Type: Article

References (57)

1. Hughes JT. Neuropathology of the spinal cord. Neurol Clin. 1991; 9: 551-71.
2. Blits B, Boer GJ, Verhaagen J. Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration. Cell Transplant. 2002; 11: 593-613.
3. McDonald JW, Liu XZ, Qu Y, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med. 1999; 5: 1410-2.
4. Ziv Y, Avidan H, Pluchino S, et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci USA. 2006; 103: 13174-9.
5. Nandoe Tewarie RD, Hurtado A, Levi AD, et al. Bone marrow stromal cells for repair of the spinal cord: towards clinical application. Cell Transplant. 2006; 15: 563-77.
6. Kubasak MD, Jindrich DL, Zhong H, et al. OEG implantation and step training enhance hindlimb-stepping ability in adult spinal transected rats. Brain. 2008; 131: 264-76.
7. Pearse DD, Pereira FC, Marcillo AE, et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med. 2004; 10: 610-6.
8. Kang HM, Kim J, Park S, et al. Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice. Stem Cells. 2009; 27: 1999-2008.
9. Thomas S, Thomas M, Wincker P, et al. Human neural crest cells display molecular and phenotypic hallmarks of stem cells. Hum Mol Genet. 2008; 17: 3411-25.
10. Oh JS, Kim KN, An SS, et al. Cotransplantation of mouse neural stem cells (mNSCs) with adipose tissue-derived mesenchymal stem cells improves mNSC survival in a rat spinal cord injury model. Cell Transplant. 2011; 20: 837-49.
11. Hill CE, Hurtado A, Blits B, et al. Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord. Eur J Neurosci. 2007; 26: 1433-45.
12. Hill CE, Moon LD, Wood PM, et al. Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia. 2006; 53: 338-43.
13. Kwon BK, Okon E, Hillyer J, et al. A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma. 2011; 28: 1545-88.
14. Baptiste DC, Fehlings MG. Pharmacological approaches to repair the injured spinal cord. J Neurotrauma. 2006; 23: 318-34.
15. Numakawa Y, Matsumoto T, Yokomaku D, et al. 17beta-estradiol protects cortical neurons against oxidative stress-induced cell death through reduction in the activity of mitogen-activated protein kinase and in the accumulation of intracellular calcium. Endocrinology. 2007; 148: 627-37.
16. Suzuki S, Brown CM, Dela CCD, et al. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci USA. 2007; 104: 6013-8.
17. Matejuk A, Bakke AC, Hopke C, et al. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. J Neurosci Res. 2004; 77: 119-26.
18. Ritz MF, Hausmann ON. Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats. Brain Res. 2008; 1203: 177-88.
19. Wang S, Ren P, Li X, et al. 17beta-estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis gene BCL2. J Mol Neurosci. 2011; 45: 236-45.
20. Takao T, Flint N, Lee L, et al. 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J Neurochem. 2004; 89: 660-73.
21. Leal AM, Begona RM, Martinez R, et al. Cytoprotective actions of estrogens against tert-butyl hydroperoxide-induced toxicity in hepatocytes. Biochem Pharmacol. 1998; 56: 1463-9.
22. Richardson TE, Yang SH, Wen Y, et al. Estrogen protection in Friedreich's ataxia skin fibroblasts. Endocrinology. 2011; 152: 2742-9.
23. Biewenga E, Cabell L, Audesirk T. Estradiol and raloxifene protect cultured SN4741 neurons against oxidative stress. Neurosci Lett. 2005; 373: 179-83.
24. Sribnick EA, Wingrave JM, Matzelle DD, et al. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res. 2005; 82: 283-93.
25. Cuzzocrea S, Genovese T, Mazzon E, et al. Effect of 17beta-estradiol on signal transduction pathways and secondary damage in experimental spinal cord trauma. Shock. 2008; 29: 362-71.
26. Siriphorn A, Dunham KA, Chompoopong S, et al. Postinjury administration of 17beta-estradiol induces protection in the gray and white matter with associated functional recovery after cervical spinal cord injury in male rats. J Comp Neurol. 2012; 520: 2630-46.
27. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7.
28. Ouyang HW, Cao T, Zou XH, et al. Mesenchymal stem cell sheets revitalize nonviable dense grafts: implications for repair of large-bone and tendon defects. Transplantation. 2006; 82: 170-4.
29. Bi Y, Ehirchiou D, Kilts TM, et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med. 2007; 13: 1219-27.
30. Hermann A, Gastl R, Liebau S, et al. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci. 2004; 117: 4411-22.
31. Chen X, Song XH, Yin Z, et al. Stepwise differentiation of human embryonic stem cells promotes tendon regeneration by secreting fetal tendon matrix and differentiation factors. Stem Cells. 2009; 27: 1276-87.
32. Arvanian VL, Schnell L, Lou L, et al. Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fibers to motoneurons. Exp Neurol. 2009; 216: 471-80.
33. Liu Y, Wang X, Lu CC, et al. Repulsive Wnt signaling inhibits axon regeneration after CNS injury. J Neurosci. 2008; 28: 8376-82.
34. Teng YD, Lavik EB, Qu X, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA. 2002; 99: 3024-9.
35. Sellers DL, Maris DO, Horner PJ. Postinjury niches induce temporal shifts in progenitor fates to direct lesion repair after spinal cord injury. J Neurosci. 2009; 29: 6722-33.
36. Sullivan-Brown J, Bisher ME, Burdine RD. Embedding, serial sectioning and staining of zebrafish embryos using JB-4 resin. Nat Protoc. 2011; 6: 46-55.
37. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995; 12: 1-21.
38. Behrmann DL, Bresnahan JC, Beattie MS, et al. Spinal cord injury produced by consistent mechanical displacement of the cord in rats: behavioral and histologic analysis. J Neurotrauma. 1992; 9: 197-217.
39. Z'Graggen WJ, Metz GA, Kartje GL, et al. Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J Neurosci. 1998; 18: 4744-57.
40. Billon N, Iannarelli P, Monteiro MC, et al. The generation of adipocytes by the neural crest. Development. 2007; 134: 2283-92.
41. Le Douarin NM, Calloni GW, Dupin E. The stem cells of the neural crest. Cell Cycle. 2008; 7: 1013-9.
42. Le Lievre CS, Schweizer GG, Ziller CM, et al. Restrictions of developmental capabilities in neural crest cell derivatives as tested by in vivo transplantation experiments. Dev Biol. 1980; 77: 362-78.
43. Wrage PC, Tran T, To K, et al. The neuro-glial properties of adipose-derived adult stromal (ADAS) cells are not regulated by Notch 1 and are not derived from neural crest lineage. PLoS ONE. 2008; 3: e1453.
44. Takashima Y, Era T, Nakao K, et al. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell. 2007; 129: 1377-88.
45. Kokai LE, Rubin JP, Marra KG. The potential of adipose-derived adult stem cells as a source of neuronal progenitor cells. Plast Reconstr Surg. 2005; 116: 1453-60.
46. Chang C, Niu D, Zhou H, et al. Mesenchymal stroma cells improve hyperglycemia and insulin deficiency in the diabetic porcine pancreatic microenvironment. Cytotherapy. 2008; 10: 796-805.
47. Wang X, Chen T, Leng L, et al. MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation. Cancer Res. 2012; 72: 2867-78.
48. Yamasaki K, Setoguchi T, Takenouchi T, et al. Stem cell factor prevents neuronal cell apoptosis after acute spinal cord injury. Spine (Phila Pa 1976). 2009; 34: 323-7.
49. Park HW, Lim MJ, Jung H, et al. Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury. Glia. 2010; 58: 1118-32.
50. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995; 267: 1456-62.
51. Byrnes KR, Stoica BA, Fricke S, et al. Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. Brain. 2007; 130: 2977-92.
52. Beattie MS. Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol Med. 2004; 10: 580-3.
53. Bunge MB. Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med. 2008; 31: 262-9.
54. Yune TY, Park HG, Lee JY, et al. Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation. J Neurotrauma. 2008; 25: 1121-31.
55. Yune TY, Kim SJ, Lee SM, et al. Systemic administration of 17beta-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma. 2004; 21: 293-306.
56. Crowe MJ, Bresnahan JC, Shuman SL, et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med. 1997; 3: 73-6.
57. Sribnick EA, Samantaray S, Das A, et al. Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats. J Neurosci Res. 2010; 88: 1738-50.